 This study found that breast cancer patients had different lipid profiles than healthy controls. Specifically, they had lower levels of total cholesterol, triglycerides, and phospholipids in their high-density lipoprotein, HDL. Additionally, the ability of HDL to remove cellular cholesterol was reduced in breast cancer patients. This suggests that HDL may play a role in the development of breast cancer. This article was authored by Maria Isabella-Bloys-Alvys-Caldus-Sawada, Monique de Fatima-Melo-Santana, Mosania-Race, and others.